morphimmune.com
morphimmune.com
Claim pageClaim
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$32.1M
2 rounds on record
Latest round
$15M
Venture round · May 2023 · 3 yr ago
Team
51-200
employees, estimated range
Backers
1
EcoR1 Capital
The money's age
Long since its last round
41 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
May 17, 2023
Board appointment Franklyn Prendergast M.D. Ph.D., Director · SEC Form D
May 5, 2023
Raised a round Venture round $15M · SEC Form D
Feb 4, 2022
Raised a round Venture round $17.1M · SEC Form D
2020
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | May 2023 | $15M | — | SEC Form D |
| Venture round | Feb 2022 | $17.1M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | MorphImmune Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Ronald MartellDirectorSEC Form D
Clay Siegall Ph.D.Executive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
EcoR1 Capital People
Ronald Martell
Director
Clay Siegall Ph.D.
Executive Officer, Director
Isaac Barchas
Director
Sunil Singhal M.D.
Director
Philip Low Ph.D.
Director
Franklyn Prendergast M.D. Ph.D.
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
West Lafayette
United States
HQ
50-200 est. staff